- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Speech biomarkers are techniques for identifying diseases by the rhythm, frequency, pitch, and breathing of human voices
The Speech Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Speech Biomarkers market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.
Speech biomarkers are the most advantageous objective identification methods for diseases such as psychology, which not only have high recognition rate, but also have the advantages of simple collection, high privacy, and low cost. The screening and monitoring of mental and psychological diseases can be conveniently, objectively and efficiently realized through mobile devices.
Market segmentation
Speech Biomarkers market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Frequency
Amplitude
Error Rate
Pronunciation Time
Market segment by Application, can be divided into
Mental Disorder
Respiratory Failure
Other
Market segment by players, this report covers
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Speech Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Speech Biomarkers, with recent developments and future plans
Chapter 3, the Speech Biomarkers competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Speech Biomarkers market forecast, by regions, with revenue, from 2023 to 2029.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.
Chapter 7 and 8, to describe Speech Biomarkers research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Speech Biomarkers
1.2 Classification of Speech Biomarkers by Type
1.2.1 Overview: Global Speech Biomarkers Market Size by Type: 2022 Versus 2028
1.2.2 Global Speech Biomarkers Revenue Market Share by Type in 2029
1.2.3 Frequency
1.2.4 Amplitude
1.2.5 Error Rate
1.2.6 Pronunciation Time
1.3 Global Speech Biomarkers Market by Application
1.3.1 Overview: Global Speech Biomarkers Market Size by Application: 2023 Versus 2029
1.3.2 Mental Disorder
1.3.3 Respiratory Failure
1.3.4 Other
1.4 Global Speech Biomarkers Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Speech Biomarkers Market Drivers
1.5.2 Speech Biomarkers Market Restraints
1.5.3 Speech Biomarkers Trends Analysis
2 Company Profiles
2.1 Boston Technology Corp.
2.1.1 Boston Technology Corp. Details
2.1.2 Boston Technology Corp. Major Business
2.1.3 Boston Technology Corp. Speech Biomarkers Product and Solutions
2.1.4 Boston Technology Corp. Recent Developments and Future Plans
2.2 Cogito Corp.
2.2.1 Cogito Corp. Details
2.2.2 Cogito Corp. Major Business
2.2.3 Cogito Corp. Speech Biomarkers Product and Solutions
2.2.4 Cogito Corp. Recent Developments and Future Plans
2.3 IBM Corp.
2.3.1 IBM Corp. Details
2.3.2 IBM Corp. Major Business
2.3.3 IBM Corp. Speech Biomarkers Product and Solutions
2.3.4 IBM Corp. Recent Developments and Future Plans
2.4 conversation HEALTH Group
2.4.1 conversation HEALTH Group Details
2.4.2 conversation HEALTH Group Major Business
2.4.3 conversation HEALTH Group Speech Biomarkers Product and Solutions
2.4.4 conversation HEALTH Group Recent Developments and Future Plans
2.5 Winterlight Labs Inc.
2.5.1 Winterlight Labs Inc. Details
2.5.2 Winterlight Labs Inc. Major Business
2.5.3 Winterlight Labs Inc. Speech Biomarkers Product and Solutions
2.5.4 Winterlight Labs Inc. Recent Developments and Future Plans
2.6 Vocalis Health, Inc.
2.6.1 Vocalis Health, Inc. Details
2.6.2 Vocalis Health, Inc. Major Business
2.6.3 Vocalis Health, Inc. Speech Biomarkers Product and Solutions
2.6.4 Vocalis Health, Inc. Recent Developments and Future Plans
2.7 Mayo Clinic Inc.
2.7.1 Mayo Clinic Inc. Details
2.7.2 Mayo Clinic Inc. Major Business
2.7.3 Mayo Clinic Inc. Speech Biomarkers Product and Solutions
2.7.4 Mayo Clinic Inc. Recent Developments and Future Plans
2.8 Medical Information Technology, Inc.
2.8.1 Medical Information Technology, Inc. Details
2.8.2 Medical Information Technology, Inc. Major Business
2.8.3 Medical Information Technology, Inc. Speech Biomarkers Product and Solutions
2.8.4 Medical Information Technology, Inc. Recent Developments and Future Plans
2.9 Sonde Health, Inc.
2.9.1 Sonde Health, Inc. Details
2.9.2 Sonde Health, Inc. Major Business
2.9.3 Sonde Health, Inc. Speech Biomarkers Product and Solutions
2.9.4 Sonde Health, Inc. Recent Developments and Future Plans
2.10 PureTech Health Plc
2.10.1 PureTech Health Plc Details
2.10.2 PureTech Health Plc Major Business
2.10.3 PureTech Health Plc Speech Biomarkers Product and Solutions
2.10.4 PureTech Health Plc Recent Developments and Future Plans
2.11 Orbita Inc.
2.11.1 Orbita Inc. Details
2.11.2 Orbita Inc. Major Business
2.11.3 Orbita Inc. Speech Biomarkers Product and Solutions
2.11.4 Orbita Inc. Recent Developments and Future Plans
2.12 MediTECH Electronic GmbH
2.12.1 MediTECH Electronic GmbH Details
2.12.2 MediTECH Electronic GmbH Major Business
2.12.3 MediTECH Electronic GmbH Speech Biomarkers Product and Solutions
2.12.4 MediTECH Electronic GmbH Recent Developments and Future Plans
2.13 Kintsugi Mindful Wellness
2.13.1 Kintsugi Mindful Wellness Details
2.13.2 Kintsugi Mindful Wellness Major Business
2.13.3 Kintsugi Mindful Wellness Speech Biomarkers Product and Solutions
2.13.4 Kintsugi Mindful Wellness Recent Developments and Future Plans
2.14 Ellipsis Health
2.14.1 Ellipsis Health Details
2.14.2 Ellipsis Health Major Business
2.14.3 Ellipsis Health Speech Biomarkers Product and Solutions
2.14.4 Ellipsis Health Recent Developments and Future Plans
2.15 Winter Light Labs
2.15.1 Winter Light Labs Details
2.15.2 Winter Light Labs Major Business
2.15.3 Winter Light Labs Speech Biomarkers Product and Solutions
2.15.4 Winter Light Labs Recent Developments and Future Plans
2.16 Voice Health Tech
2.16.1 Voice Health Tech Details
2.16.2 Voice Health Tech Major Business
2.16.3 Voice Health Tech Speech Biomarkers Product and Solutions
2.16.4 Voice Health Tech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Speech Biomarkers Revenue and Share by Players (2023 & 2029)
3.2 Speech Biomarkers Players Head Office, Products and Services Provided
3.3 Speech Biomarkers Mergers & Acquisitions
3.4 Speech Biomarkers New Entrants and Expansion Plans
4 Global Speech Biomarkers Forecast by Region
4.1 Global Speech Biomarkers Market Size by Region: 2023 VS 2029
4.2 Global Speech Biomarkers Market Size by Region, (2023-2029)
4.3 North America
4.3.1 Key Companies of Speech Biomarkers in North America
4.3.2 Current Situation and Forecast of Speech Biomarkers in North America
4.3.3 North America Speech Biomarkers Market Size and Prospect (2023-2029)
4.4 Europe
4.4.1 Key Companies of Speech Biomarkers in Europe
4.4.2 Current Situation and Forecast of Speech Biomarkers in Europe
4.4.3 Europe Speech Biomarkers Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
4.5.1 Key Companies of Speech Biomarkers in Asia-Pacific
4.5.2 Current Situation and Forecast of Speech Biomarkers in Asia-Pacific
4.5.3 Asia-Pacific Speech Biomarkers Market Size and Prospect (2023-2029)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Speech Biomarkers in South America
4.6.2 Current Situation and Forecast of Speech Biomarkers in South America
4.6.3 South America Speech Biomarkers Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
4.7.1 Key Companies of Speech Biomarkers in Middle East & Africa
4.7.2 Current Situation and Forecast of Speech Biomarkers in Middle East & Africa
4.7.3 Middle East & Africa Speech Biomarkers Market Size and Prospect (2023-2029)
5 Market Size Segment by Type
5.1 Global Speech Biomarkers Market Forecast by Type (2023-2029)
5.2 Global Speech Biomarkers Market Share Forecast by Type (2023-2029)
6 Market Size Segment by Application
6.1 Global Speech Biomarkers Market Forecast by Application (2023-2029)
6.2 Global Speech Biomarkers Market Share Forecast by Application (2023-2029)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
List of Tables
Table 1. Global Speech Biomarkers Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Speech Biomarkers Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Boston Technology Corp. Corporate Information, Head Office, and Major Competitors
Table 4. Boston Technology Corp. Major Business
Table 5. Boston Technology Corp. Speech Biomarkers Product and Solutions
Table 6. Cogito Corp. Corporate Information, Head Office, and Major Competitors
Table 7. Cogito Corp. Major Business
Table 8. Cogito Corp. Speech Biomarkers Product and Solutions
Table 9. IBM Corp. Corporate Information, Head Office, and Major Competitors
Table 10. IBM Corp. Major Business
Table 11. IBM Corp. Speech Biomarkers Product and Solutions
Table 12. conversation HEALTH Group Corporate Information, Head Office, and Major Competitors
Table 13. conversation HEALTH Group Major Business
Table 14. conversation HEALTH Group Speech Biomarkers Product and Solutions
Table 15. Winterlight Labs Inc. Corporate Information, Head Office, and Major Competitors
Table 16. Winterlight Labs Inc. Major Business
Table 17. Winterlight Labs Inc. Speech Biomarkers Product and Solutions
Table 18. Vocalis Health, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Vocalis Health, Inc. Major Business
Table 20. Vocalis Health, Inc. Speech Biomarkers Product and Solutions
Table 21. Mayo Clinic Inc. Corporate Information, Head Office, and Major Competitors
Table 22. Mayo Clinic Inc. Major Business
Table 23. Mayo Clinic Inc. Speech Biomarkers Product and Solutions
Table 24. Medical Information Technology, Inc. Corporate Information, Head Office, and Major Competitors
Table 25. Medical Information Technology, Inc. Major Business
Table 26. Medical Information Technology, Inc. Speech Biomarkers Product and Solutions
Table 27. Sonde Health, Inc. Corporate Information, Head Office, and Major Competitors
Table 28. Sonde Health, Inc. Major Business
Table 29. Sonde Health, Inc. Speech Biomarkers Product and Solutions
Table 30. PureTech Health Plc Corporate Information, Head Office, and Major Competitors
Table 31. PureTech Health Plc Major Business
Table 32. PureTech Health Plc Speech Biomarkers Product and Solutions
Table 33. Orbita Inc. Corporate Information, Head Office, and Major Competitors
Table 34. Orbita Inc. Major Business
Table 35. Orbita Inc. Speech Biomarkers Product and Solutions
Table 36. MediTECH Electronic GmbH Corporate Information, Head Office, and Major Competitors
Table 37. MediTECH Electronic GmbH Major Business
Table 38. MediTECH Electronic GmbH Speech Biomarkers Product and Solutions
Table 39. Kintsugi Mindful Wellness Corporate Information, Head Office, and Major Competitors
Table 40. Kintsugi Mindful Wellness Major Business
Table 41. Kintsugi Mindful Wellness Speech Biomarkers Product and Solutions
Table 42. Ellipsis Health Corporate Information, Head Office, and Major Competitors
Table 43. Ellipsis Health Major Business
Table 44. Ellipsis Health Speech Biomarkers Product and Solutions
Table 45. Winter Light Labs Corporate Information, Head Office, and Major Competitors
Table 46. Winter Light Labs Major Business
Table 47. Winter Light Labs Speech Biomarkers Product and Solutions
Table 48. Voice Health Tech Corporate Information, Head Office, and Major Competitors
Table 49. Voice Health Tech Major Business
Table 50. Voice Health Tech Speech Biomarkers Product and Solutions
Table 51. Global Speech Biomarkers Revenue (USD Million) by Players (2023 & 2029)
Table 52. Global Speech Biomarkers Revenue Share by Players (2023 & 2029)
Table 53. Speech Biomarkers Players Head Office, Products and Services Provided
Table 54. Speech Biomarkers Mergers & Acquisitions in the Past Five Years
Table 55. Speech Biomarkers New Entrants and Expansion Plans
Table 56. Global Market Speech Biomarkers Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 57. Global Speech Biomarkers Revenue Market Share by Region (2023-2029)
Table 58. Key Companies of Speech Biomarkers in North America
Table 59. Current Situation and Forecast of Speech Biomarkers in North America
Table 60. Key Companies of Speech Biomarkers in Europe
Table 61. Current Situation and Forecast of Speech Biomarkers in Europe
Table 62. Key Companies of Speech Biomarkers in Asia-Pacific
Table 63. Current Situation and Forecast of Speech Biomarkers in Asia-Pacific
Table 64. Key Companies of Speech Biomarkers in China
Table 65. Key Companies of Speech Biomarkers in Japan
Table 66. Key Companies of Speech Biomarkers in South Korea
Table 67. Key Companies of Speech Biomarkers in South America
Table 68. Current Situation and Forecast of Speech Biomarkers in South America
Table 69. Key Companies of Speech Biomarkers in Middle East & Africa
Table 70. Current Situation and Forecast of Speech Biomarkers in Middle East & Africa
Table 71. Global Speech Biomarkers Revenue Forecast by Type (2023-2029)
Table 72. Global Speech Biomarkers Revenue Forecast by Application (2023-2029)
List of Figures
Figure 1. Speech Biomarkers Picture
Figure 2. Global Speech Biomarkers Revenue Market Share by Type in 2029
Figure 3. Frequency
Figure 4. Amplitude
Figure 5. Error Rate
Figure 6. Pronunciation Time
Figure 7. Speech Biomarkers Revenue Market Share by Application in 2029
Figure 8. Mental Disorder Picture
Figure 9. Respiratory Failure Picture
Figure 10. Other Picture
Figure 11. Global Speech Biomarkers Market Size, (USD Million): 2023 VS 2029
Figure 12. Global Speech Biomarkers Revenue and Forecast (2023-2029) & (USD Million)
Figure 13. Speech Biomarkers Market Drivers
Figure 14. Speech Biomarkers Market Restraints
Figure 15. Speech Biomarkers Market Trends
Figure 16. Boston Technology Corp. Recent Developments and Future Plans
Figure 17. Cogito Corp. Recent Developments and Future Plans
Figure 18. IBM Corp. Recent Developments and Future Plans
Figure 19. conversation HEALTH Group Recent Developments and Future Plans
Figure 20. Winterlight Labs Inc. Recent Developments and Future Plans
Figure 21. Vocalis Health, Inc. Recent Developments and Future Plans
Figure 22. Mayo Clinic Inc. Recent Developments and Future Plans
Figure 23. Medical Information Technology, Inc. Recent Developments and Future Plans
Figure 24. Sonde Health, Inc. Recent Developments and Future Plans
Figure 25. PureTech Health Plc Recent Developments and Future Plans
Figure 26. Orbita Inc. Recent Developments and Future Plans
Figure 27. MediTECH Electronic GmbH Recent Developments and Future Plans
Figure 28. Kintsugi Mindful Wellness Recent Developments and Future Plans
Figure 29. Ellipsis Health Recent Developments and Future Plans
Figure 30. Winter Light Labs Recent Developments and Future Plans
Figure 31. Voice Health Tech Recent Developments and Future Plans
Figure 32. Global Speech Biomarkers Revenue Market Share by Region (2023-2029)
Figure 33. Global Speech Biomarkers Revenue Market Share by Region in 2029
Figure 34. North America Speech Biomarkers Revenue (USD Million) and Growth Rate (2023-2029)
Figure 35. Europe Speech Biomarkers Revenue (USD Million) and Growth Rate (2023-2029)
Figure 36. Asia-Pacific Speech Biomarkers Revenue (USD Million) and Growth Rate (2023-2029)
Figure 37. South America Speech Biomarkers Revenue (USD Million) and Growth Rate (2023-2029)
Figure 38. Middle East & Africa Speech Biomarkers Revenue (USD Million) and Growth Rate (2023-2029)
Figure 39. Global Speech Biomarkers Market Share Forecast by Type (2023-2029)
Figure 40. Global Speech Biomarkers Market Share Forecast by Application (2023-2029)
Figure 41. Methodology
Figure 42. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
